Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Gynecologic 1Classical hematology 1

Conditions

Breast Neoplasms 3Lung Neoplasms 2Ovarian Neoplasms 1Neoplasms 1Genetic Predisposition to Disease 1Fanconi Anemia, Complementation Group D1 1Early-onset Gastrointestinal Cancer 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Letrozole 221Capecitabine 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 132Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Demography × Clear all
NCT07179809 2025-09-18

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
100 enrolled
Breast

Breast Neoplasms

NCT03346161 2019-09-06

Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach

Washington University School of Medicine

Phase 1 Completed
120 enrolled 19 charts
Breast

Breast Neoplasms

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

M.D. Anderson Cancer Center

Completed
176 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡